KEY TERMS
|
|
Issuer:
|
Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.
|
Guarantee:
|
All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.
|
Underlying
shares:
|
Underlying
shares
|
Initial
share price*
|
Coupon
barrier price**
|
Final
barrier price***
|
Shares
of Common Stock of American Airlines Group Inc.
|
$46.10
|
$23.05
|
$23.05
|
Shares
of Common Stock of Celgene Corporation
|
$119.46
|
$59.73
|
$59.73
|
Shares
of Common Stock of Nordstrom, Inc.
|
$43.94
|
$21.97
|
$21.97
|
* The closing price of the applicable underlying shares
on the pricing date
** For each of the underlying shares, 50% of the applicable
initial share price
*** For each of the underlying shares, 50% of the applicable
initial share price
|
Aggregate stated principal
amount:
|
$2,530,000
|
Stated principal amount:
|
$1,000 per security
|
Pricing date:
|
February 23, 2017
|
Issue date:
|
February 28, 2017
|
Valuation dates:
|
The 23rd day of each month, beginning in March 2017 and ending on February 23, 2019 (the “final valuation date”), each subject to postponement if such date is not a scheduled trading day for any of the underlying shares or if certain market disruption events occur with respect to any of the underlying shares
|
Maturity date:
|
Unless earlier redeemed, February 28, 2019
|
Contingent coupon payment dates:
|
For each valuation date, the fifth business day after such valuation date, except that the contingent coupon payment date for the final valuation date will be the maturity date
|
Contingent coupon:
|
On each monthly contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon equal to 0.9167% (approximately 11.00% per annum) of the stated principal amount of the securities
if and only if
the closing price of the worst performing underlying shares on the related valuation date is greater than or equal to the applicable coupon barrier price.
If the closing price of the worst performing underlying shares on any monthly valuation date is less than the applicable coupon barrier price, you will not receive any contingent coupon payment on the related contingent coupon payment date.
|
Payment at maturity:
|
If the securities are not automatically redeemed prior to maturity,
you will be entitled to receive at maturity for each security you then hold:
▪
If the final share price of the worst performing underlying shares on the final valuation date is
greater than
or equal to
the applicable final barrier price: $1,000
plus
the contingent coupon payment due at maturity
▪
If the final share price of the worst performing underlying shares on the final valuation date is
less than
the applicable final barrier price:
$1,000 × the share performance
factor of the worst performing underlying shares on the final valuation date
If the final share price of the worst performing underlying
shares on the final valuation date is less than the applicable final barrier price, you will receive less than 50% of the stated
principal amount of your securities, and possibly nothing, at maturity, and you will not receive any contingent coupon payment
at maturity.
|
Underwriting fee and issue price:
|
Issue price
(1)
|
Underwriting fee
(2)
|
Proceeds to issuer
|
Per security:
|
$1,000.00
|
$33.50
|
$966.50
|
Total:
|
$2,530,000.00
|
$84,755.00
|
$2,445,245.00
|
(Key Terms
continued on next page)
(1) On the date of this pricing supplement, the estimated value
of the securities is $920.40 per security, which is less than the issue price. The estimated value of the securities is based on
Citigroup Global Markets Inc.’s (“CGMI”) proprietary pricing models and our internal funding rate. It is not
an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI
or any other person may be willing to buy the securities from you at any time after issuance. See “Valuation of the Securities”
in this pricing supplement.
(2) For more information on the distribution of the securities,
see “Supplemental Plan of Distribution” in this pricing supplement. In addition to the underwriting fee, CGMI and its
affiliates may profit from hedging activity related to this offering, even if the value of the securities declines. See “Use
of Proceeds and Hedging” in the accompanying prospectus.
Investing in the securities
involves risks not associated with an investment in conventional debt securities. See “Summary Risk Factors” beginning
on page PS-5.
Neither
the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved
of the securities or determined that this pricing supplement and the accompanying product supplement, prospectus supplement and
prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
You should read this pricing
supplement together with the accompanying product supplement, prospectus supplement and prospectus, each of which can be accessed
via the hyperlinks below:
Product Supplement No. EA-04-04 dated October 14, 2016
Prospectus and Prospectus Supplement each dated October 14, 2016
The securities
are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental
agency, nor are they obligations of, or guaranteed by, a bank.
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
KEY TERMS (continued)
|
Automatic early redemption:
|
If, on any potential redemption date, the closing price of the worst
performing underlying shares is greater than or equal to the applicable initial share price, each security you then hold will
be automatically redeemed on the related contingent coupon payment date for an amount in cash equal to $1,000
plus
the related contingent coupon payment
|
Potential redemption dates:
|
The valuation dates occurring in February, May, August and November of each year, beginning
in May 2017 and ending in November 2018
|
Final share price:
|
For each of the underlying shares, the applicable closing price on the final valuation date
|
Share performance factor:
|
For each of the underlying shares on any valuation date, the applicable closing price on
that valuation date
divided by
the applicable initial share price
|
Worst performing underlying shares:
|
For any valuation date, the underlying shares with the lowest share performance factor on
that valuation date
|
Listing:
|
The securities will not be listed on any securities exchange
|
CUSIP / ISIN:
|
17324CEZ5 / US17324CEZ59
|
Underwriter:
|
CGMI, an affiliate of the issuer, acting as principal
|
Additional
Information
General.
The terms of the securities are set forth in
the accompanying product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying
product supplement, prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement.
For example, certain events may occur that could affect whether you receive a contingent coupon payment on a contingent coupon
payment date as well as your payment at maturity or, in the case of a delisting of the underlying shares, could give us the right
to call the securities prior to maturity for an amount that may be less than the stated principal amount. These events, including
market disruption events and other events affecting the underlying shares, and their consequences are described in the accompanying
product supplement in the sections “Description of the Securities—Certain Additional Terms for Securities Linked to
Company Shares or ETF Shares—Consequences of a Market Disruption Event; Postponement of a Valuation Date,” “—Dilution
and Reorganization Adjustments” and “—Delisting of Company Shares,” and not in this pricing supplement.
It is important that you read the accompanying product supplement, prospectus supplement and prospectus together with this pricing
supplement in connection with your investment in the securities. Certain terms used but not defined in this pricing supplement
are defined in the accompanying product supplement.
Postponement of a valuation date.
If a scheduled valuation
date is not a scheduled trading day for any of the underlying shares or if a market disruption event occurs with respect to any
of the underlying shares on a scheduled valuation date, that valuation date will be subject to postponement as described in the
accompanying product supplement in the section “Description of the Securities—Certain Additional Terms for Securities
Linked to Company Shares or ETF Shares—Consequences of a Market Disruption Event; Postponement of a Valuation Date.”
If a scheduled valuation date is postponed, the closing price of each of the underlying shares in respect of that valuation date
will be determined based on (i) for any underlying shares for which the originally scheduled valuation date is a scheduled trading
day and as to which a market disruption event does not occur on the originally scheduled valuation date, the closing price of such
underlying shares on the originally scheduled valuation date and (ii) for any other underlying shares, the closing price of such
underlying shares on the valuation date as postponed (or, if earlier, the first scheduled trading day for such underlying shares
following the originally scheduled valuation date on which a market disruption event did not occur with respect to such underlying
shares).
Dilution and Reorganization Adjustments.
With respect
to the underlying shares, the initial share price, the coupon barrier price and the final barrier price are each a “Relevant
Price” for purposes of the section “Description of the Securities—Certain Additional Terms for Securities Linked
to Company Shares or ETF Shares—Dilution and Reorganization Adjustments” in the accompanying product supplement. Accordingly,
the initial share price, the coupon barrier price and the final barrier price applicable to each of the underlying shares are each
subject to adjustment upon the occurrence of any of the events described in that section.
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
Hypothetical
Examples
The examples below illustrate how to determine whether a contingent
coupon will be paid with respect to a monthly valuation date and how to calculate the payment at maturity on the securities, assuming
the securities are not automatically redeemed prior to maturity. You should understand that the term of the securities, and your
opportunity to receive the contingent coupon payments on the securities, may be limited to as short as three months if the securities
are automatically redeemed prior to the maturity date. Unless earlier redeemed, during the term of the securities, there are twenty-four
valuation dates. For ease of analysis, figures in the table below may have been rounded.
The examples below are based on the following values in order
to illustrate how the securities work:
Underlying
shares
|
Initial
share price
|
Coupon
barrier price
|
Final
barrier price
|
Shares
of common stock of American Airlines Group Inc.
|
$46.10
|
$23.05
(50% of the applicable initial share price)
|
$23.05
(50% of the applicable initial share price)
|
Shares
of common stock of Celgene Corporation
|
$119.46
|
$59.73
(50% of the applicable initial share price)
|
$59.73
(50% of the applicable initial share price)
|
Shares
of common stock of Nordstrom, Inc.
|
$43.94
|
$21.97
(50% of the applicable initial share price)
|
$21.97
(50% of the applicable initial share price)
|
Contingent
coupon rate:
|
11.00%
per annum (approximately 0.9167% paid monthly)
|
Hypothetical Examples of Monthly Contingent
Coupon Payments and any Payment upon Automatic Early Redemption with Respect to a Monthly Valuation Date that is also a Potential
Redemption Date
Set forth below are three hypothetical examples of the calculation of the contingent coupon payment with respect to a hypothetical
monthly valuation date that is also a potential redemption date.
|
Hypothetical
closing price of the shares of common stock of American Airlines Group Inc.
|
Hypothetical
closing price of the shares of common stock of Celgene Corporation
|
Hypothetical
closing price of the shares of common stock of Nordstrom, Inc.
|
Hypothetical
contingent coupon payment per security and any payment upon an automatic early redemption
|
Example
1
|
$55.32
(Share
performance factor =
$55.32 / $46.10 = 1.20)
|
$101.54
(Share
performance factor =
$101.54 / $119.46 = 0.85)
|
$28.56
(Share
performance factor =
$28.56 / $43.94 = 0.65)
|
$8.542
|
Example
2
|
$20.75
(Share
performance factor =
$20.75 / $46.10 = 0.45)
|
$143.35
(Share
performance factor =
$143.35 / $119.46 = 1.20)
|
$48.33
(Share
performance factor =
$48.33 / $43.94 = 1.10)
|
$0.00
|
Example
3
|
$50.71
(Share
performance factor =
$50.71 / $46.10 = 1.10)
|
$125.43
(Share
performance factor =
$125.43 / $119.46 = 1.05)
|
$52.73
(Share
performance factor =
$52.73 / $43.94 = 1.20)
|
$1,008.542
($1,000 stated principal amount per security
plus
the related contingent coupon payment)
|
Example 1:
On the
hypothetical valuation date, the shares of common stock of Nordstrom, Inc. have the lowest share performance factor and, therefore,
are the worst performing underlying shares. In this scenario, the closing price of the worst performing underlying shares is
greater
than
the applicable coupon barrier price but
less than
the applicable initial share price. As a result, investors in
the securities would receive the contingent coupon payment of $8.542 per security on the related contingent coupon payment date
and the securities would not be automatically called.
Example 2:
On the
hypothetical valuation date, the shares of common stock of American Airlines Group Inc. have the lowest share performance factor
and, therefore, are the worst performing underlying shares. In this scenario, the closing price of the worst performing underlying
shares is
less than
the applicable coupon barrier price and
less than
the applicable initial share price. As a result,
investors would not receive any payment on the related contingent coupon payment date, even though the other underlying shares
have appreciated from their applicable initial share prices, and the securities would not be automatically called.
Investors in the securities
will not receive a contingent coupon payment with respect to a valuation date if, on that valuation date, the closing price of
the worst performing underlying shares is less than the applicable coupon barrier price.
Example 3:
On the
hypothetical valuation date, the hypothetical closing prices of all of the underlying shares are
greater than
their applicable
coupon barrier prices and their applicable initial share prices. In this scenario, the closing price of the worst performing underlying
shares is
greater than
the applicable initial share price and the securities would be automatically redeemed on the related
contingent coupon payment date for an amount in cash equal to $1,000
plus
the related contingent coupon payment, or $1,008.542.
If
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
the monthly valuation
date were not also a potential redemption date, the securities would not be automatically redeemed on the related contingent coupon
payment date.
Hypothetical Examples of the Payment at
Maturity on the Securities
The following examples illustrate the hypothetical payment at maturity on the securities as determined based on the applicable
final share prices of the underlying shares on the final valuation date, assuming the securities have not been earlier automatically
redeemed.
|
Hypothetical
final share price of the shares of common stock of American Airlines Group Inc.
|
Hypothetical
final share price of the shares of common stock of Celgene Corporation
|
Hypothetical
final share price of the shares of common stock of Nordstrom, Inc.
|
Hypothetical
payment at maturity per security
|
Example
4
|
$46.56
(Share
performance factor =
$46.56 / $46.10 = 1.01)
|
$131.41
(Share
performance factor =
$131.41 / $119.46 = 1.10)
|
$46.14
(Share
performance factor =
$46.14 / $43.94 = 1.05)
|
$1,008.542
|
Example
5
|
$41.49
(Share
performance factor =
$41.49 / $46.10 = 0.90)
|
$35.84
(Share
performance factor =
$35.84 / $119.46 = 0.30)
|
$35.15
(Share
performance factor =
$35.15 / $43.94 = 0.80)
|
$300.00
|
Example
6
|
$32.27
(Share
performance factor =
$32.27 / $46.10 = 0.70)
|
$71.68
(Share
performance factor =
$71.68 / $119.46 = 0.60)
|
$0.00
(Share
performance factor =
$0.00 / $43.94 = 0.00)
|
$0.00
|
Example 4:
In this
example, the shares of common stock of American Airlines Group Inc. are the worst performing underlying shares. In this scenario,
the final share price of the worst performing underlying shares is greater than the applicable final barrier price. Accordingly,
at maturity, you would receive the stated principal amount of the securities
plus
the contingent coupon payment of $8.542
per security, but you would not participate in the appreciation of any of the underlying shares.
Example 5:
In this
example, the shares of common stock of Celgene Corporation are the worst performing underlying shares. In this scenario, the final
share price of the worst performing underlying shares is less than the applicable final barrier price. Accordingly, at maturity,
you would receive a payment per security calculated as follows:
Payment at maturity =
$1,000 × share performance factor of the shares of common stock of Celgene Corporation on the final valuation date
= $1,000 × 0.30
= $300
In this scenario, you
would receive significantly less than the stated principal amount of your securities at maturity. You would incur a loss based
on the performance of the worst performing underlying shares, even though the final share prices of the other underlying shares
are greater than the applicable final barrier prices.
In addition, because the final share price of the worst performing underlying
shares is below the applicable coupon barrier price, you will not receive any monthly contingent coupon payment.
Example 6:
In this
example, the shares of common stock of Nordstrom, Inc. are the worst performing underlying shares and their final share price is
less than the applicable final barrier price. Accordingly, at maturity, you would receive a payment per security calculated as
follows:
Payment at maturity =
$1,000 × share performance factor of the shares of common stock of Nordstrom, Inc. on the final valuation date
= $1,000 × 0.00
= $0
In this scenario, because
the closing price of the worst performing underlying shares on the final valuation date is $0, you would lose your entire investment
in the securities. In addition, because the final share price of the worst performing underlying shares is below the applicable
coupon barrier price, you will not receive any monthly contingent coupon payment.
If the closing price of
the worst performing underlying shares were less than the applicable coupon barrier price on each valuation date and less than
the final barrier price on the final valuation date, you would not have received any monthly contingent coupon payments and, in
addition, you would incur a significant loss on your securities at maturity.
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
Summary Risk
Factors
An investment in the securities is significantly riskier than
an investment in conventional debt securities. The securities are subject to all of the risks associated with an investment in
our conventional debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our
obligations under the securities, and are also subject to risks associated with each of the underlying shares. Accordingly, the
securities are suitable only for investors who are capable of understanding the complexities and risks of the securities. You should
consult your own financial, tax and legal advisers as to the risks of an investment in the securities and the suitability of the
securities in light of your particular circumstances.
The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment
in the securities contained in the section “Risk Factors Relating to the Securities” beginning on page EA-6 in the
accompanying product supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement
and in the documents incorporated by reference in the accompanying prospectus, including Citigroup Inc.’s most recent Annual
Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup
Inc. more generally.
|
▪
|
You may lose some or all of your investment.
Unlike conventional debt securities, the securities do not provide for
the repayment of the stated principal amount at maturity in all circumstances. If the securities are not automatically redeemed
prior to maturity, your payment at maturity will depend on the performance of the worst performing underlying shares on the final
valuation date. If the closing price of the worst performing underlying shares on the final valuation date is less than the applicable
final barrier price, you will lose 1% of the stated principal amount of the securities for every 1% by which the worst performing
underlying shares have declined from their initial share price, regardless of the performance of the other underlying shares. There
is no minimum payment at maturity on the securities, and you may lose up to all of your investment.
|
|
▪
|
You will not receive any contingent coupon payment for any month in which the closing price of the worst performing underlying
shares is less than the applicable coupon barrier price on the related valuation date.
A contingent coupon payment will be
made on a contingent coupon payment date if and only if the closing price of the worst performing underlying shares on the related
valuation date is greater than or equal to the applicable coupon barrier price. If the closing price of the worst performing underlying
shares is less than the applicable coupon barrier price on any monthly valuation date, you will not receive any contingent coupon
payment on the related contingent coupon payment date. If the closing price of the worst performing underlying shares is below
the applicable coupon barrier price on each valuation date, you will not receive any contingent coupon payments over the term of
the securities.
|
|
▪
|
The securities are subject to the risks of all of the underlying shares and will be negatively affected if any of the underlying
shares perform poorly, even if the other underlying shares perform well.
You are subject to risks associated with all of the
underlying shares. If any of the underlying shares perform poorly, you will be negatively affected, even if the other underlying
shares perform well. The securities are not linked to a basket composed of the underlying shares, where the better performance
of one or two could ameliorate the poor performance of the other. Instead, you are subject to the full risks of whichever of the
underlying shares are the worst performing underlying shares.
|
|
▪
|
You will not benefit in any way from the performance of the better performing underlying shares.
The return on the securities
depends solely on the performance of the worst performing underlying shares, and you will not benefit in any way from the performance
of the better performing underlying shares. The securities may underperform a similar investment in all of the underlying shares
or a similar alternative investment linked to a basket composed of the underlying shares, since in either such case the performance
of the better performing underlying shares would be blended with the performance of the worst performing underlying shares, resulting
in a better return than the return of the worst performing underlying shares.
|
|
▪
|
You will be subject to risks relating to the relationship among the underlying shares.
It is preferable from your perspective
for the underlying shares to be correlated with each other, in the sense that they tend to increase or decrease at similar times
and by similar magnitudes. By investing in the securities, you assume the risk that the underlying shares will not exhibit this
relationship. The less correlated the underlying shares, the more likely it is that any one of the underlying shares will perform
poorly over the term of the securities. All that is necessary for the securities to perform poorly is for one of the underlying
shares to perform poorly; the performance of the underlying shares that are not the worst performing underlying shares is not relevant
to your return on the securities at maturity or upon an earlier automatic redemption. It is impossible to predict what the relationship
among the underlying shares will be over the term of the securities.
|
|
▪
|
Higher contingent coupon rates are associated with greater risk.
The securities offer contingent coupon payments at
an annualized rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt
securities of the same maturity. This higher potential yield is associated with greater levels of expected risk as of the pricing
date for the securities, including the risk that you may not receive a contingent coupon payment on one or more, or any, contingent
coupon payment dates and the risk that what you receive at maturity may be worth significantly less than the stated principal amount
of your securities at maturity. The volatility of and the correlation among the underlying shares are important factors affecting
these risks. Greater expected volatility of and lower expected correlation among the underlying shares as of the pricing date may
result in a higher contingent coupon rate, but would also represent a greater expected likelihood as of the pricing date that the
closing price of the worst performing underlying shares will be less than the applicable coupon barrier price on one or more valuation
dates, such that you will not receive one or more, or any, contingent coupon payments during the term of the securities, and that
the
|
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
closing price of the worst performing underlying shares
will be less than the applicable final barrier price on the final valuation date, such that you will not be repaid the stated principal
amount of your securities at maturity.
|
▪
|
You may not be adequately compensated for assuming the downside risk of the worst performing underlying shares.
The
potential contingent coupon payments on the securities are the compensation you receive for assuming the downside risk of the worst
performing underlying shares, as well as all the other risks of the securities. That compensation is effectively “at risk”
and may, therefore, be less than you currently anticipate. First, the actual yield you realize on the securities could be lower
than you anticipate because the coupon is “contingent” and you may not receive a contingent coupon payment on one or
more, or any, of the contingent coupon payment dates. Second, the contingent coupon payments are the compensation you receive not
only for the downside risk of the worst performing underlying shares, but also for all of the other risks of the securities, including
the risk that the securities may be automatically redeemed prior to maturity, interest rate risk and our and Citigroup Inc.’s
credit risk. If those other risks increase or are otherwise greater than you currently anticipate, the contingent coupon payments
may turn out to be inadequate to compensate you for all the risks of the securities, including the downside risk of the worst performing
underlying shares.
|
|
▪
|
The securities may be automatically called prior to maturity, limiting your opportunity to receive contingent coupon payments.
On any potential redemption date, beginning in May 2017 and ending in November 2018, the securities will be automatically called
if the closing price of the worst performing underlying shares on that potential redemption date is greater than or equal to the
applicable initial share price. Thus, the term of the securities may be limited to as short as three months. If the securities
are called prior to maturity, you will not receive any additional contingent coupon payments. Moreover, you may not be able to
reinvest your funds in another investment that provides a similar yield with a similar level of risk.
|
|
▪
|
The securities offer downside exposure to the underlying shares, but no upside exposure to the underlying shares.
You
will not participate in any appreciation in the prices of the underlying shares over the term of the securities. Consequently,
your return on the securities will be limited to the contingent coupon payments you receive, if any, and may be significantly less
than the return on the underlying shares over the term of the securities. In addition, you will not receive any dividends or other
distributions or any other rights with respect to the underlying shares.
|
|
▪
|
The performance of the securities will depend on the closing prices of the underlying shares solely on the relevant valuation
dates, which makes the securities particularly sensitive to the volatility of the underlying shares.
Whether the contingent
coupon will be paid for any given month and whether the securities will be automatically redeemed prior to maturity will depend
on the closing prices of the underlying shares solely on the applicable valuation dates, regardless of the closing prices of the
underlying shares on other days during the term of the securities. If the securities are not automatically redeemed, what you receive
at maturity will depend solely on the closing price of the worst performing underlying shares on the final valuation date, and
not on any other day during the term of the securities. Because the performance of the securities depends on the closing prices
of the underlying shares on a limited number of dates, the securities will be particularly sensitive to volatility in the closing
prices of the underlying shares. You should understand that each of the underlying shares has historically been highly volatile.
|
|
▪
|
The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.
If we default
on our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive any amounts
owed to you under the securities.
|
|
▪
|
The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.
The
securities will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities.
CGMI currently intends to make a secondary market in relation to the securities and to provide an indicative bid price for the
securities on a daily basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI’s sole
discretion, taking into account prevailing market conditions and other relevant factors, and will not be a representation by CGMI
that the securities can be sold at that price, or at all. CGMI may suspend or terminate making a market and providing indicative
bid prices without notice, at any time and for any reason. If CGMI suspends or terminates making a market, there may be no secondary
market at all for the securities because it is likely that CGMI will be the only broker-dealer that is willing to buy your securities
prior to maturity. Accordingly, an investor must be prepared to hold the securities until maturity.
|
|
▪
|
The estimated value of the securities on the pricing date, based on CGMI’s proprietary pricing models and our internal
funding rate, is less than the issue price
. The difference is attributable to certain costs associated with selling, structuring
and hedging the securities that are included in the issue price. These costs include (i) the selling concessions paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering
of the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates
in connection with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities
because, if they were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities
are also likely to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price
the securities. See “The estimated value of the securities would be lower if it were calculated based on our secondary market
rate” below.
|
|
▪
|
The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.
CGMI
derived the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing
so, it may have made discretionary judgments about the inputs to its models, such as the volatility of and correlation among the
underlying shares, the dividend yields on the underlying shares and interest rates. CGMI’s views on these inputs may differ
from
|
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
your or others’ views, and as an underwriter
in this offering, CGMI’s interests may conflict with yours. Both the models and the inputs to the models may prove to be
wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities
set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the
securities for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated
value of the securities. Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated
value.
|
▪
|
The estimated value of the securities would be lower if it were calculated based on our secondary market rate.
The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate
at which we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than
our secondary market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any
purchases of the securities from you in the secondary market. If the estimated value included in this pricing supplement were based
on our secondary market rate, rather than our internal funding rate, it would likely be lower. We determine our internal funding
rate based on factors such as the costs associated with the securities, which are generally higher than the costs associated with
conventional debt securities, and our liquidity needs and preferences. Our internal funding rate is not the same as the coupon
that is payable on the securities.
|
Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities,
but subject to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined
measure of our creditworthiness, but rather reflects the market’s perception of our parent company’s creditworthiness
as adjusted for discretionary factors such as CGMI’s preferences with respect to purchasing the securities prior to maturity.
|
▪
|
The estimated value of the securities is not an indication
of the price, if any, at which CGMI or any other person may be willing to buy the securities from you in the secondary market.
Any such secondary market price will fluctuate over the term of the securities based on the market and other factors described
in the next risk factor. Moreover, unlike the estimated value included in this pricing supplement, any value of the securities
determined for purposes of a secondary market transaction will be based on our secondary market rate, which will likely result
in a lower value for the securities than if our internal funding rate were used. In addition, any secondary market price for the
securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the securities
to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions. As a result,
it is likely that any secondary market price for the securities will be less than the issue price.
|
|
▪
|
The value of the securities prior to maturity will fluctuate based on many unpredictable factors.
The value of your
securities prior to maturity will fluctuate based on the price and volatility of the underlying shares and a number of other factors,
including the correlation among the underlying shares, dividend yields on the underlying shares, interest rates generally, the
time remaining to maturity and our and Citigroup Inc.’s creditworthiness, as reflected in our secondary market rate. Changes
in the prices of the underlying shares may not result in a comparable change in the value of your securities. You should understand
that the value of your securities at any time prior to maturity may be significantly less than the issue price.
|
|
▪
|
Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on
any brokerage account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.
The amount
of this temporary upward adjustment will steadily decline to zero over the temporary adjustment period. See “Valuation of
the Securities” in this pricing supplement.
|
|
▪
|
Our offering of the securities is not a recommendation of any of the underlying shares.
The fact that we are offering
the securities does not mean that we believe that investing in an instrument linked to any of the underlying shares is likely to
achieve favorable returns. In fact, as we are part of a global financial institution, our affiliates may have positions (including
short positions) in the underlying shares or in instruments related to the underlying shares and may publish research or express
opinions, that in each case are inconsistent with an investment linked to the underlying shares. These and other of our affiliates’
activities may affect the prices of the underlying shares in a way that has a negative impact on your interests as a holder of
the securities.
|
|
▪
|
The prices of the underlying shares may be adversely affected by our or our affiliates’ hedging and other trading
activities.
We have hedged our obligations under the securities through CGMI or other of our affiliates, who have taken positions
directly in the underlying shares and other financial instruments related to the underlying shares and may adjust such positions
during the term of the securities. Our affiliates also trade the underlying shares and other financial instruments related to the
underlying shares on a regular basis (taking long or short positions or both), for their accounts, for other accounts under their
management or to facilitate transactions on behalf of customers. These activities could affect the prices of the underlying shares
in a way that negatively affects the value of the securities. They could also result in substantial returns for us or our affiliates
while the value of the securities declines.
|
|
▪
|
We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates’ business
activities.
Our affiliates may currently or from time to time engage in business with any underlying share issuer, including
extending loans to, making equity investments in or providing advisory services to those issuers. In the course of this business,
we or our affiliates may acquire non-public information about the underlying share issuers, which we will not disclose to you.
Moreover,
|
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
if any of our affiliates is or becomes
a creditor of any such issuer, they may exercise any remedies against that issuer that are available to them without regard to
your interests.
|
▪
|
You will have no rights and will not receive dividends with respect to the underlying shares.
As of February 23, 2017,
Celgene Corporation does not pay regular dividends. However, that may change, and if Celgene Corporation starts to pay dividends
during the term of the securities, you should understand that you will not receive such dividend payments under the securities.
In addition, i
f any change to the underlying shares is proposed, such as an amendment
to any underlying share issuer’s certificate of incorporation, you will not have the right to vote on such change. Any such
change may adversely affect the market price of the applicable underlying shares.
|
|
▪
|
Even if any underlying share issuer pays a dividend that it identifies as special or extraordinary, no adjustment will be
required under the securities for that dividend unless it meets the criteria specified in the accompanying product supplement.
In general, an adjustment will not be made under the terms of the securities for any cash dividend paid on any of the underlying
shares unless the amount of the dividend per share, together with any other dividends paid in the same fiscal quarter, exceeds
the dividend paid per share in the most recent fiscal quarter by an amount equal to at least 10% of the closing price of the applicable
shares on the date of declaration of the dividend. Any dividend will reduce the closing price of the applicable underlying shares
by the amount of the dividend per share. If the applicable underlying share issuer pays any dividend for which an adjustment is
not made under the terms of the securities, holders of the securities may be adversely affected. See “Description of the
Securities—Certain Additional Terms for Securities Linked to Company Shares or ETF Shares—Dilution and Reorganization
Adjustments—Certain Extraordinary Cash Dividends” in the accompanying product supplement.
|
|
▪
|
The securities will not be adjusted for all events that could affect the price of any of the underlying shares.
For
example, we will not make any adjustment for ordinary dividends or extraordinary dividends that do not meet the criteria described
above, partial tender offers or additional public offerings of the underlying shares. Moreover, the adjustments we do make may
not fully offset the dilutive or adverse effect of the particular event. Investors in the securities may be adversely affected
by such an event in a circumstance in which a direct holder of any of the underlying shares would not.
|
|
▪
|
If any of the underlying shares are delisted, we may call the securities prior to maturity for an amount that may be less
than the stated principal amount.
If we exercise this call right, you will receive the amount described under “Description
of the Securities—Certain Additional Terms for Securities Linked to Company Shares or ETF Shares—Delisting of Company
Shares” in the accompanying product supplement. This amount may be less, and possibly significantly less, than the stated
principal amount of the securities.
|
|
▪
|
The securities may become linked to shares of an issuer other than any original underlying share issuer upon the occurrence
of a reorganization event or upon the delisting of any of the underlying shares.
For example, if any underlying share issuer
enters into a merger agreement that provides for holders of the applicable underlying shares to receive stock of another entity,
the stock of such other entity will become the applicable underlying shares for all purposes of the securities upon consummation
of the merger. Additionally, if the applicable underlying shares are delisted and we do not exercise our call right, the calculation
agent may, in its sole discretion, select shares of another issuer to be the applicable underlying shares. See “Description
of the Securities—Certain Additional Terms for Securities Linked to Company Shares or ETF Shares—Dilution and Reorganization
Adjustments” and “—Delisting of Company Shares” in the accompanying product supplement.
|
|
▪
|
The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.
If certain events occur, such as market disruption events, corporate events with respect to any of the underlying share issuers
that may require a dilution adjustment or the delisting of the applicable underlying shares, CGMI, as calculation agent, will be
required to make discretionary judgments that could significantly affect what you receive at maturity. In making these judgments,
the calculation agent’s interests as an affiliate of ours could be adverse to your interests as a holder of the securities.
|
▪
|
The U.S. federal tax consequences of an investment in the securities are unclear.
There is no direct legal authority regarding the proper U.S. federal tax treatment of the securities, and we do not plan to
request a ruling from the Internal Revenue Service (the “IRS”). Consequently, significant aspects of the tax treatment
of the securities are uncertain, and the IRS or a court might not agree with the treatment of the securities as described in “United
States Federal Tax Considerations” below. If the IRS were successful in asserting an alternative treatment, the tax consequences
of ownership and disposition of the securities might be materially and adversely affected. As described in the accompanying product
supplement under “United States Federal Tax Considerations,” in 2007 the U.S. Treasury Department and the IRS released
a notice requesting comments on various issues regarding the U.S. federal income tax treatment of “prepaid forward contracts”
and similar instruments. While it is not clear whether the securities would be viewed as similar to the typical prepaid forward
contract described in the notice, it is possible that any Treasury regulations or other guidance promulgated after consideration
of these issues could materially and adversely affect the tax consequences of an investment in the securities, including the character
and timing of income or loss and the degree, if any, to which income realized by non-U.S. persons should be subject to withholding
tax, possibly with retroactive effect. You should read carefully the discussion under “United States Federal Tax Considerations”
and “Risk Factors Relating to the Securities” in the accompanying product supplement and “United States Federal
Tax Considerations” in this pricing supplement. You should also consult your tax adviser regarding the U.S. federal tax
consequences of an investment in the securities, as well as tax consequences arising under the laws of any state, local or non-U.S.
taxing jurisdiction.
|
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
As described in “United States Federal Tax Considerations”
below, in connection with any information reporting requirements we may have in respect of the securities under applicable law,
we intend to treat a portion of each coupon payment as attributable to interest and the remainder to option premium. However, in
light of the uncertain treatment of the securities, it is possible that other persons having withholding or information reporting
responsibility in respect of the securities may treat a security differently, for instance, by treating the entire coupon payment
as ordinary income at the time received or accrued by a holder and/or treating some or all of each coupon payment on a security
to a non-U.S. investor as subject to withholding tax at a rate of 30%.
In addition, Section 871(m) of the Internal Revenue
Code of 1986, as amended (the “Code”), imposes a withholding tax of up to 30% on “dividend equivalents”
paid or deemed paid to non-U.S. investors in respect of certain financial instruments linked to U.S. equities. In light of IRS
regulations providing a general exemption for financial instruments issued in 2017 that do not have a “delta” of one,
the securities should not be subject to withholding under Section 871(m). However, the IRS could challenge this conclusion.
If withholding applies to the securities, we will not
be required to pay any additional amounts with respect to amounts so withheld.
Information About American Airlines Group Inc.
American Airlines Group Inc. is a holding company whose primary
business activity is the operation of a major network carrier through its principal wholly owned mainline operating subsidiary,
American. The common stock of American Airlines Group Inc. is registered under the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). Information provided to or filed with the SEC by American Airlines Group Inc. pursuant to the
Exchange Act can be located by reference to the SEC file number 001-08400 through the SEC’s website at http://www.sec.gov.
In addition, information regarding American Airlines Group Inc. may be obtained from other sources including, but not limited to,
press releases, newspaper articles and other publicly disseminated documents. The common stock of American Airlines Group Inc.
trades on the NASDAQ Global Select Market under the ticker symbol “AAL.”
This pricing supplement relates only to the securities offered
hereby and does not relate to the common stock of American Airlines Group Inc. or other securities of American Airlines Group Inc.
We have derived all disclosures contained in this pricing supplement regarding American Airlines Group Inc. from the publicly available
documents described above. In connection with the offering of the securities, none of Citigroup Global Markets Holdings Inc., Citigroup
Inc. or CGMI has participated in the preparation of such documents or made any due diligence inquiry with respect to American Airlines
Group Inc.
The securities represent obligations of Citigroup Global Markets
Holdings Inc. (guaranteed by Citigroup Inc.) only. American Airlines Group Inc. is not involved in any way in this offering and
has no obligation relating to the securities or to holders of the securities.
Neither we nor any of our affiliates make any representation
to you as to the performance of the common stock of American Airlines Group Inc.
Historical Information
The graph below shows the closing prices of the shares of common
stock of American Airlines Group Inc. for each day such price was available from December 9, 2013 to February 23, 2017. The table
that follows shows the high and low closing prices of, and dividends paid on, the common stock of American Airlines Group Inc.
for each quarter in that same period. We obtained the closing prices and other information below from Bloomberg L.P., without independent
verification. If certain corporate transactions occurred during the historical period shown below, including, but not limited to,
spin-offs or mergers, then the closing prices of the shares of common stock of American Airlines Group Inc. shown below for the
period prior to the occurrence of any such transaction have been adjusted by Bloomberg L.P. as if any such transaction had occurred
prior to the first day in the period shown below. You should not take the historical prices of the common stock of American Airlines
Group Inc. as an indication of future performance.
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
Common Stock of American
Airlines Group Inc. – Historical Closing Prices
December 9, 2013 to February
23, 2017
|
|
* The red line indicates the
coupon barrier price and final barrier price with respect to American Airlines Group Inc. of $23.05, equal to 50.00% of the applicable
closing price on February 23, 2017.
Common Stock of American Airlines Group Inc.
|
High
|
Low
|
Dividends
|
2013
|
|
|
|
Fourth Quarter (beginning December 9, 2013)
|
$26.61
|
$24.60
|
$0.00000
|
2014
|
|
|
|
First Quarter
|
$39.02
|
$25.36
|
$0.00000
|
Second Quarter
|
$44.55
|
$33.37
|
$0.00000
|
Third Quarter
|
$43.86
|
$35.03
|
$0.10000
|
Fourth Quarter
|
$53.63
|
$28.58
|
$0.10000
|
2015
|
|
|
|
First Quarter
|
$55.76
|
$46.53
|
$0.10000
|
Second Quarter
|
$50.44
|
$47.50
|
$0.10000
|
Third Quarter
|
$43.99
|
$37.50
|
$0.10000
|
Fourth Quarter
|
$46.50
|
$38.13
|
$0.10000
|
2016
|
|
|
|
First Quarter
|
$43.47
|
$35.55
|
$0.10000
|
Second Quarter
|
$41.34
|
$25.27
|
$0.10000
|
Third Quarter
|
$39.35
|
$28.35
|
$0.10000
|
Fourth Quarter
|
$49.64
|
$37.38
|
$0.10000
|
2017
|
|
|
|
First Quarter (through February 23, 2017)
|
$49.59
|
$44.01
|
$0.00000
|
The closing price of the common
stock of American Airlines Group Inc. on February 23, 2017 was $46.10.
On January 27, 2017, American Airlines Group Inc. declared a
cash dividend of $0.10000 per share of common stock payable on February 27, 2017. We make no representation as to the amount of
dividends, if any, that may be paid on the common stock of American Airlines Group Inc. in the future. In any event, as an investor
in the securities, you will not be entitled to receive dividends, if any, that may be payable on the common stock of American Airlines
Group Inc.
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
Information
About Celgene Corporation
Celgene Corporation is a biopharmaceutical company that focuses
on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
The common stock of Celgene Corporation is registered under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”). Information provided to or filed with the SEC by Celgene Corporation pursuant to the Exchange Act can be located by
reference to the SEC file number 001-34912 through the SEC’s website at http://www.sec.gov. In addition, information regarding
Celgene Corporation may be obtained from other sources including, but not limited to, press releases, newspaper articles and other
publicly disseminated documents. The common stock of Celgene Corporation trades on the NASDAQ Global Select Market under the ticker
symbol “CELG.”
This pricing supplement relates only to the securities offered
hereby and does not relate to the common stock of Celgene Corporation or other securities of Celgene Corporation. We have derived
all disclosures contained in this pricing supplement regarding Celgene Corporation from the publicly available documents described
above. In connection with the offering of the securities, none of Citigroup Global Markets Holdings Inc., Citigroup Inc. or CGMI
has participated in the preparation of such documents or made any due diligence inquiry with respect to Celgene Corporation.
The securities represent obligations of Citigroup Global Markets
Holdings Inc. (guaranteed by Citigroup Inc.) only. Celgene Corporation is not involved in any way in this offering and has no obligation
relating to the securities or to holders of the securities.
Neither we nor any of our affiliates make any representation
to you as to the performance of the common stock of Celgene Corporation.
Historical Information
The graph below shows the closing prices of the shares of common
stock of Celgene Corporation for each day such price was available from January 3, 2012 to February 23, 2017. The table that follows
shows the high and low closing prices of, and dividends paid on, the common stock of Celgene Corporation for each quarter in that
same period. We obtained the closing prices and other information below from Bloomberg L.P., without independent verification.
If certain corporate transactions occurred during the historical period shown below, including, but not limited to, spin-offs or
mergers, then the closing prices of the shares of common stock of Celgene Corporation shown below for the period prior to the occurrence
of any such transaction have been adjusted by Bloomberg L.P. as if any such transaction had occurred prior to the first day in
the period shown below. You should not take the historical prices of the common stock of Celgene Corporation as an indication of
future performance.
Common Stock
of Celgene Corporation – Historical Closing Prices
December 9, 2013
to February 23, 2017
|
|
* The red line indicates the
coupon barrier price and final barrier price with respect to Celgene Corporation of $59.73, equal to 50.00% of the applicable closing
price on February 23, 2017.
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
Common Stock of Celgene Corporation
|
High
|
Low
|
Dividends
|
2012
|
|
|
|
First Quarter
|
$39.25
|
$33.61
|
$0.00000
|
Second Quarter
|
$40.15
|
$29.73
|
$0.00000
|
Third Quarter
|
$38.64
|
$31.48
|
$0.00000
|
Fourth Quarter
|
$41.04
|
$35.65
|
$0.00000
|
2013
|
|
|
|
First Quarter
|
$57.96
|
$40.55
|
$0.00000
|
Second Quarter
|
$65.09
|
$56.10
|
$0.00000
|
Third Quarter
|
$77.31
|
$59.46
|
$0.00000
|
Fourth Quarter
|
$85.39
|
$72.23
|
$0.00000
|
2014
|
|
|
|
First Quarter
|
$85.97
|
$69.65
|
$0.00000
|
Second Quarter
|
$86.80
|
$68.45
|
$0.00000
|
Third Quarter
|
$96.21
|
$83.13
|
$0.00000
|
Fourth Quarter
|
$118.68
|
$86.38
|
$0.00000
|
2015
|
|
|
|
First Quarter
|
$128.50
|
$110.51
|
$0.00000
|
Second Quarter
|
$120.34
|
$107.54
|
$0.00000
|
Third Quarter
|
$139.01
|
$104.79
|
$0.00000
|
Fourth Quarter
|
$127.20
|
$106.55
|
$0.00000
|
2016
|
|
|
|
First Quarter
|
$117.96
|
$96.69
|
$0.00000
|
Second Quarter
|
$110.57
|
$94.85
|
$0.00000
|
Third Quarter
|
$116.27
|
$100.25
|
$0.00000
|
Fourth Quarter
|
$124.16
|
$97.63
|
$0.00000
|
2017
|
|
|
|
First Quarter (through February 23, 2017)
|
$121.16
|
$111.53
|
$0.00000
|
The closing price of the common stock of Celgene Corporation
on February 23, 2017 was $119.46.
We make no representation as to the amount of dividends, if any,
that may be paid on the common stock of Celgene Corporation in the future. In any event, as an investor in the securities, you
will not be entitled to receive dividends, if any, that may be payable on the common stock of Celgene Corporation.
Information
About Nordstrom, Inc.
Nordstrom, Inc. a fashion specialty retailer, offering apparel,
shoes, cosmetics and accessories through its retail stores, website and catalogs, and related consumer financings. The common stock
of Nordstrom, Inc. is registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Information
provided to or filed with the SEC by Nordstrom, Inc. pursuant to the Exchange Act can be located by reference to the SEC file number
001-15059 through the SEC’s website at http://www.sec.gov. In addition, information regarding Nordstrom, Inc. may be obtained
from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents.
The common stock of Nordstrom, Inc. trades on the New York Stock Exchange under the ticker symbol “JWN.”
This pricing supplement relates only to the securities offered
hereby and does not relate to the common stock of Nordstrom, Inc. or other securities of Nordstrom, Inc. We have derived all disclosures
contained in this pricing supplement regarding Nordstrom, Inc. from the publicly available documents described above. In connection
with the offering of the securities, none of Citigroup Global Markets Holdings Inc., Citigroup Inc. or CGMI has participated in
the preparation of such documents or made any due diligence inquiry with respect to Nordstrom, Inc.
The securities represent obligations of Citigroup Global Markets
Holdings Inc. (guaranteed by Citigroup Inc.) only. Nordstrom, Inc. is not involved in any way in this offering and has no obligation
relating to the securities or to holders of the securities.
Neither we nor any of our affiliates make any representation
to you as to the performance of the common stock of Nordstrom, Inc.
Historical Information
The graph below shows the closing prices of the shares of common
stock of Nordstrom, Inc. for each day such price was available from January 3, 2012 to February 23, 2017. The table that follows
shows the high and low closing prices of, and dividends paid on, the common stock of Nordstrom, Inc. for each quarter in that same
period. We obtained the closing prices and other information below from Bloomberg L.P., without independent verification. If certain
corporate transactions occurred during the historical period shown below, including, but not limited to, spin-offs or mergers,
then the closing prices of the shares of common stock of Nordstrom, Inc. shown below for the period prior to the occurrence of
any such transaction have been adjusted by Bloomberg L.P. as if any such transaction had
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
occurred prior to the first day in the period shown below. You
should not take the historical prices of the common stock of Nordstrom, Inc. as an indication of future performance.
Common Stock
of Nordstrom, Inc. – Historical Closing Prices
January 3, 2012 to February
23, 2017
|
|
* The red line indicates the
coupon barrier price and final barrier price with respect to Nordstrom, Inc. of $21.97, equal to 50.00% of the applicable closing
price on February 23, 2017.
Common Stock of Nordstrom, Inc.
|
High
|
Low
|
Dividends
|
2012
|
|
|
|
First Quarter
|
$55.72
|
$48.46
|
$0.27000
|
Second Quarter
|
$57.20
|
$46.80
|
$0.27000
|
Third Quarter
|
$58.03
|
$50.33
|
$0.27000
|
Fourth Quarter
|
$58.20
|
$51.40
|
$0.27000
|
2013
|
|
|
|
First Quarter
|
$56.47
|
$52.45
|
$0.30000
|
Second Quarter
|
$61.44
|
$54.45
|
$0.30000
|
Third Quarter
|
$62.67
|
$55.49
|
$0.30000
|
Fourth Quarter
|
$63.43
|
$55.62
|
$0.30000
|
2014
|
|
|
|
First Quarter
|
$62.63
|
$55.38
|
$0.33000
|
Second Quarter
|
$70.55
|
$60.46
|
$0.33000
|
Third Quarter
|
$70.63
|
$65.11
|
$0.33000
|
Fourth Quarter
|
$79.39
|
$67.58
|
$0.33000
|
2015
|
|
|
|
First Quarter
|
$82.32
|
$75.71
|
$0.37000
|
Second Quarter
|
$80.50
|
$72.64
|
$0.37000
|
Third Quarter
|
$79.52
|
$70.44
|
$0.37000
|
Fourth Quarter
|
$75.12
|
$49.81
|
$5.22000
|
2016
|
|
|
|
First Quarter
|
$58.52
|
$45.45
|
$0.37000
|
Second Quarter
|
$57.23
|
$36.20
|
$0.37000
|
Third Quarter
|
$52.96
|
$37.46
|
$0.37000
|
Fourth Quarter
|
$61.49
|
$47.83
|
$0.37000
|
2017
|
|
|
|
First Quarter (through February 23, 2017)
|
$48.92
|
$42.78
|
$0.00000
|
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
The closing price of the common stock of Nordstrom, Inc. on February
23, 2017 was $43.94.
On February 17, 2017, Nordstrom, Inc. declared a cash dividend
of $0.37000 per share of common stock payable on March 15, 2017. We make no representation as to the amount of dividends, if any,
that may be paid on the common stock of Nordstrom, Inc. in the future. In any event, as an investor in the securities, you will
not be entitled to receive dividends, if any, that may be payable on the common stock of Nordstrom, Inc.
United States
Federal Tax Considerations
You should read carefully the discussion under “United
States Federal Tax Considerations” and “Risk Factors Relating to the Securities” in the accompanying product
supplement and “Summary Risk Factors” in this pricing supplement.
Due to the lack of any controlling legal authority, there is
substantial uncertainty regarding the U.S. federal tax consequences of an investment in the securities. In connection with any
information reporting requirements we may have in respect of the securities under applicable law, we intend (in the absence of
an administrative determination or judicial ruling to the contrary) to treat a security as a put option (the “Put Option”)
written by you with respect to the underlying shares, secured by a cash deposit equal to the stated principal amount of the security
(the “Deposit”). In the opinion of our tax counsel, Davis Polk & Wardwell LLP, which is based on current market
conditions, this treatment of the securities is reasonable under current law; however, our tax counsel has advised us that it is
unable to conclude affirmatively that this treatment is more likely than not to be upheld, and that alternative treatments are
possible. Under this treatment:
|
·
|
a portion of each coupon payment made with respect to the securities will be attributable to interest on the Deposit; and
|
|
·
|
the remainder will represent premium attributable to your grant of the Put Option (“Put Premium”).
|
We will treat 17.16% of each coupon payment as interest on the
Deposit and 82.84% as Put Premium for each security.
Assuming the treatment of a security as a Put Option and a Deposit
is respected, amounts treated as interest on the Deposit should be taxed as ordinary interest income, while the Put Premium should
not be taken into account prior to maturity or disposition of the securities. See “United States Federal Tax Considerations—Tax
Consequences to U.S. Holders” in the accompanying product supplement.
Subject to the discussions below under “Possible Withholding
Under Section 871(m) of the Code” and in the section of the accompanying product supplement entitled “United States
Federal Tax Considerations,” if you are a Non-U.S. Holder (as defined in the accompanying product supplement) of the securities,
under current law you generally should not be subject to U.S. federal withholding or income tax in respect of any amount paid to
you with respect to the securities, provided that (i) income in respect of the securities is not effectively connected with your
conduct of a trade or business in the United States, and (ii) you comply with the applicable certification requirements.
We do not plan to request a ruling from the IRS regarding the
treatment of the securities, and the IRS or a court might not agree with the treatment described herein. In addition, the U.S.
Treasury Department and the IRS have released a notice requesting comments on the U.S. federal income tax treatment of “prepaid
forward contracts.” While it is not clear whether the securities would be viewed as similar to the typical prepaid forward
contract described in the notice, it is possible that any Treasury regulations or other guidance promulgated after consideration
of these issues could materially and adversely affect the tax consequences of an investment in the securities, including the character
and timing of income or loss and the degree, if any, to which income realized by non-U.S. persons should be subject to withholding
tax, possibly with retroactive effect.
Possible Withholding Under Section 871(m) of the Code.
As discussed under “United States Federal Tax Considerations – Tax Consequences to Non-U.S. Holders – Possible
Withholding Under Section 871(m) of the Code” in the accompanying product supplement, Section 871(m) of the Code and Treasury
regulations promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax on dividend equivalents
paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities (“U.S. Underlying
Equities”) or indices that include U.S. Underlying Equities. Section 871(m) generally applies to instruments that substantially
replicate the economic performance of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable
Treasury regulations (a “Specified Security”). However, the regulations exempt financial instruments issued in 2017
that do not have a “delta” of one. Based on the terms of the securities and representations provided by us, our tax
counsel is of the opinion that the securities should not be treated as transactions that have a “delta” of one within
the meaning of the regulations with respect to any U.S. Underlying Equity and, therefore, should not be Specified Securities subject
to withholding tax under Section 871(m).
A determination that the securities are
not subject to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m)
is complex and its application may depend on your particular circumstances. For example, if you enter into other transactions relating
to an underlier, you could be subject to withholding tax or income tax liability under Section 871(m) even if the securities are
not Specified Securities subject to Section 871(m) as a general matter. You should consult your tax adviser regarding the potential
application of Section 871(m) to the securities.
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
While we currently do not intend to withhold on payments on
the securities to Non-U.S. Holders (subject to compliance with the applicable certification requirements and the discussions in
the accompanying product supplement regarding “FATCA”), in light of the uncertain treatment of the securities other
persons having withholding or information reporting responsibility in respect of the securities may treat some or all of each coupon
payment on a security as subject to withholding tax at a rate of 30%. Moreover, it is possible that in the future we may determine
that we should withhold at a rate of 30% on coupon payments on the securities. We will not be required to pay any additional amounts
with respect to amounts withheld.
You should read the section entitled “United States
Federal Tax Considerations” in the accompanying product supplement. The preceding discussion, when read in combination with
that section, constitutes the full opinion of Davis Polk & Wardwell LLP regarding the material U.S. federal tax consequences
of owning and disposing of the securities.
You should also consult your tax adviser regarding all aspects
of the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction.
Supplemental
Plan of Distribution
CGMI, an affiliate of Citigroup Global Markets Holdings Inc.
and the underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $33.50 for each
$1,000 security sold in this offering. CGMI will pay selected dealers not affiliated with CGMI a fixed selling concession of $33.50
for each $1,000 security they sell. For the avoidance of doubt, the fees and selling concessions described in this pricing supplement
will not be rebated if the securities are automatically redeemed prior to maturity.
CGMI is an affiliate of ours. Accordingly, this offering will
conform with the requirements addressing conflicts of interest when distributing the securities of an affiliate set forth in Rule
5121 of the Financial Industry Regulatory Authority. Client accounts over which Citigroup Inc. or its subsidiaries have investment
discretion will not be permitted to purchase the securities, either directly or indirectly, without the prior written consent of
the client.
See “Plan of Distribution; Conflicts of Interest”
in the accompanying product supplement and “Plan of Distribution” in each of the accompanying prospectus supplement
and prospectus for additional information.
A portion of the net proceeds from the sale of the securities
will be used to hedge our obligations under the securities. We have hedged our obligations under the securities through CGMI or
other of our affiliates. CGMI or such other of our affiliates may profit from this hedging activity even if the value of the securities
declines. This hedging activity could affect the closing prices of any of the underlying shares and, therefore, the value of and
your return on the securities. For additional information on the ways in which our counterparties may hedge our obligations under
the securities, see “Use of Proceeds and Hedging” in the accompanying prospectus.
Valuation of
the Securities
CGMI calculated the estimated value of the securities set forth
on the cover page of this pricing supplement based on proprietary pricing models. CGMI’s proprietary pricing models generated
an estimated value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate
the payout on the securities, which consists of a fixed-income bond (the “bond component”) and one or more derivative
instruments underlying the economic terms of the securities (the “derivative component”). CGMI calculated the estimated
value of the bond component using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the
derivative component based on a proprietary derivative-pricing model, which generated a theoretical price for the instruments that
constitute the derivative component based on various inputs, including the factors described under “Summary Risk Factors—The
value of the securities prior to maturity will fluctuate based on many unpredictable factors” in this pricing supplement,
but not including our or Citigroup Inc.’s creditworthiness. These inputs may be market-observable or may be based on assumptions
made by CGMI in its discretionary judgment.
For a period of approximately three months following issuance
of the securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will
be indicated for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also
publish through one or more financial information vendors), will reflect a temporary upward adjustment from the price or value
that would otherwise be determined. This temporary upward adjustment represents a portion of the hedging profit expected to be
realized by CGMI or its affiliates over the term of the securities. The amount of this temporary upward adjustment will decline
to zero on a straight-line basis over the three-month temporary adjustment period. However, CGMI is not obligated to buy the securities
from investors at any time. See “Summary Risk Factors—The securities will not be listed on any securities exchange
and you may not be able to sell them prior to maturity.”
Certain Selling
Restrictions
Hong Kong Special Administrative Region
The contents of this pricing supplement and the accompanying
product supplement, prospectus supplement and prospectus have not been reviewed by any regulatory authority in the Hong Kong Special
Administrative Region of the People’s Republic of China (“Hong Kong”). Investors are advised to exercise caution
in relation to the offer. If investors are in any doubt about any of the contents of this
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
pricing supplement and the accompanying product supplement, prospectus
supplement and prospectus, they should obtain independent professional advice.
The securities have not been offered or sold and will not be
offered or sold in Hong Kong by means of any document, other than
|
(i)
|
to persons whose ordinary business is to buy or sell shares or debentures (whether as principal or agent); or
|
|
(ii)
|
to “professional investors” as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong (the “Securities
and Futures Ordinance”) and any rules made under that Ordinance; or
|
|
(iii)
|
in other circumstances which do not result in the document being a “prospectus” as defined in the Companies Ordinance
(Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance; and
|
There is no advertisement, invitation or document relating to
the securities which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except
if permitted to do so under the securities laws of Hong Kong) other than with respect to securities which are or are intended to
be disposed of only to persons outside Hong Kong or only to “professional investors” as defined in the Securities and
Futures Ordinance and any rules made under that Ordinance.
Non-insured Product: These securities are not insured by any
governmental agency. These securities are not bank deposits and are not covered by the Hong Kong Deposit Protection Scheme.
Singapore
This pricing supplement and the accompanying product supplement,
prospectus supplement and prospectus have not been registered as a prospectus with the Monetary Authority of Singapore, and the
securities will be offered pursuant to exemptions under the Securities and Futures Act, Chapter 289 of Singapore (the “Securities
and Futures Act”). Accordingly, the securities may not be offered or sold or made the subject of an invitation for subscription
or purchase nor may this pricing supplement or any other document or material in connection with the offer or sale or invitation
for subscription or purchase of any securities be circulated or distributed, whether directly or indirectly, to any person in Singapore
other than (a) to an institutional investor pursuant to Section 274 of the Securities and Futures Act, (b) to a relevant person
under Section 275(1) of the Securities and Futures Act or to any person pursuant to Section 275(1A) of the Securities and Futures
Act and in accordance with the conditions specified in Section 275 of the Securities and Futures Act, or (c) otherwise pursuant
to, and in accordance with the conditions of, any other applicable provision of the Securities and Futures Act. Where the securities
are subscribed or purchased under Section 275 of the Securities and Futures Act by a relevant person which is:
|
(a)
|
a corporation (which is not an accredited investor (as defined in Section 4A of the Securities and Futures Act)) the sole business
of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited
investor; or
|
|
(b)
|
a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary is
an individual who is an accredited investor, securities (as defined in Section 239(1) of the Securities and Futures Act) of that
corporation or the beneficiaries’ rights and interests (howsoever described) in that trust shall not be transferable for
6 months after that corporation or that trust has acquired the relevant securities pursuant to an offer under Section 275 of the
Securities and Futures Act except:
|
|
(i)
|
to an institutional investor or to a relevant person defined in Section 275(2) of the Securities and Futures Act or to any
person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the Securities and Futures Act; or
|
|
(ii)
|
where no consideration is or will be given for the transfer; or
|
|
(iii)
|
where the transfer is by operation of law; or
|
|
(iv)
|
pursuant to Section 276(7) of the Securities and Futures Act; or
|
|
(v)
|
as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (shares and Debentures) Regulations 2005
of Singapore.
|
Any securities referred to herein may not be registered with
any regulator, regulatory body or similar organization or institution in any jurisdiction.
The securities are Specified Investment Products (as defined
in the Notice on Recommendations on Investment Products and Notice on the Sale of Investment Product issued by the Monetary Authority
of Singapore on 28 July 2011) that is neither listed nor quoted on a securities market or a futures market.
Non-insured Product: These securities are not insured by any
governmental agency. These securities are not bank deposits. These securities are not insured products subject to the provisions
of the Deposit Insurance and Policy Owners’ Protection Schemes Act 2011 of Singapore and are not eligible for deposit insurance
coverage under the Deposit Insurance Scheme.
Citigroup Global Markets Holdings Inc.
|
Autocallable Contingent Coupon Equity Linked Securities Based on the Worst Performing of the Common Stock of American Airlines Group Inc., the Common Stock of Celgene Corporation and the Common Stock of Nordstrom Inc. Due February 28, 2019
|
|
Validity of
the Securities
In the opinion of Davis Polk & Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the securities offered by this pricing supplement have been executed and
issued by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against
payment therefor, such securities and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup
Global Markets Holdings Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to
applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and
equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack
of bad faith), provided that such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer or
similar provision of applicable law on the conclusions expressed above. This opinion is given as of the date of this pricing supplement
and is limited to the laws of the State of New York, except that such counsel expresses no opinion as to the application of state
securities or Blue Sky laws to the securities.
In giving this opinion, Davis Polk & Wardwell LLP has assumed
the legal conclusions expressed in the opinions set forth below of Scott L. Flood, General Counsel and Secretary of Citigroup Global
Markets Holdings Inc., and Barbara Politi, Assistant General Counsel—Capital Markets of Citigroup Inc. In addition, this
opinion is subject to the assumptions set forth in the letter of Davis Polk & Wardwell LLP dated October 14, 2016, which has
been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on October 14, 2016, that the indenture has been
duly authorized, executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of
the terms of the securities nor the issuance and delivery of the securities and the related guarantee, nor the compliance by Citigroup
Global Markets Holdings Inc. and Citigroup Inc. with the terms of the securities and the related guarantee respectively, will result
in a violation of any provision of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup
Inc., as applicable, or any restriction imposed by any court or governmental body having jurisdiction over Citigroup Global Markets
Holdings Inc. or Citigroup Inc., as applicable.
In the opinion of Scott L. Flood, Secretary and General Counsel
of Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered by this pricing supplement have been duly established
under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc.
has duly authorized the issuance and sale of such securities and such authorization has not been modified or rescinded; (ii) Citigroup
Global Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture
has been duly authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery
of such indenture and of the securities offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance
by Citigroup Global Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene
its certificate of incorporation or bylaws or other constitutive documents. This opinion is given as of the date of this pricing
supplement and is limited to the laws of the State of New York.
Scott L. Flood, or other internal attorneys with whom he has
consulted, has examined and is familiar with originals, or copies certified or otherwise identified to his satisfaction, of such
corporate records of Citigroup Global Markets Holdings Inc., certificates or documents as he has deemed appropriate as a basis
for the opinions expressed above. In such examination, he or such persons has assumed the legal capacity of all natural persons,
the genuineness of all signatures (other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of
all documents submitted to him or such persons as originals, the conformity to original documents of all documents submitted to
him or such persons as certified or photostatic copies and the authenticity of the originals of such copies.
In the opinion of Barbara Politi, Assistant
General Counsel—Capital Markets of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of
Citigroup Inc. has duly authorized the guarantee of such securities by Citigroup Inc. and such authorization has not been modified
or rescinded; (ii) Citigroup Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture
has been duly authorized, executed and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and
the performance by Citigroup Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate
of incorporation or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and
is limited to the General Corporation Law of the State of Delaware.
Barbara Politi, or other internal attorneys
with whom she has consulted, has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction,
of such corporate records of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions
expressed above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness
of all signatures (other than those of officers of Citigroup Inc.), the authenticity of all documents submitted to her or such
persons as originals, the conformity to original documents of all documents submitted to her or such persons as certified or photostatic
copies and the authenticity of the originals of such copies.
Contact
Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.
©
2017 Citigroup Global Markets Inc. All rights
reserved. Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered
throughout the world.
Citigroup (NYSE:C)
Historical Stock Chart
From Aug 2024 to Sep 2024
Citigroup (NYSE:C)
Historical Stock Chart
From Sep 2023 to Sep 2024